Skip to Main content Skip to Footer content
FCS News

FCS Press Releases

FCS leaders present at AVBCC 2025 Summit
FCS Leaders Convene With Executive Peers at Value-Based Cancer Care Summit

Florida Cancer Specialists & Research Institute leaders join executive oncology peers at the Association of Value-Based Cancer Care 2025 in New York City.

23 FCS abstracts to be presented at ESMO 2025.
FCS Shaping the Future of Cancer Care at Global Congress

23 FCS abstracts to be presented at the European Society of Medical Oncology Congress 2025 including one oral presentation.

FCS participates in the 2025 NCODA International Fall Summit in Orlando, FL.
FCS Champions the Impact of Integrated Oncology At NCODA International Summit

Florida Cancer Specialists & Research Institute physician leaders and pharmacy experts share insights at 2025 NCODA International Fall Summit.

FCS hosts its 2025 Clinical Summit, bringing oncology leaders together to advance patient care, research, and collaboration across Florida.
Oncology Leaders Champion Innovation and Collaboration To Advance Cancer Care FCS Hosts 2025 Clinical Summit

Florida Cancer Specialists & Research Institute hosts its 2025 Clinical Summit, bringing oncology leaders together to advance patient care, research, and collaboration across Florida.

FCS earns ACR accreditation for all 11 radiation oncology sites, highlighting excellence in safety and patient care.
Raising the Bar in Community Cancer Care: FCS Radiation Oncology Sites Earn ACR Accreditation

Florida Cancer Specialists & Research Institute earns ACR accreditation for all 11 radiation oncology sites, highlighting excellence in safety and patient care.

FCS earns HITRUST i1 Certification, demonstrating strong cybersecurity and data protection practices across its pharmacy and data systems.
FCS Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats

FCS earns HITRUST i1 Certification, demonstrating strong cybersecurity and data protection practices across its pharmacy and data systems.

FCS physician abstract co-authors educate on processes to accelerate drug discovery and regulatory approval.
FCS Physician Leaders Examine Best Practices To Improve Speed, Efficiency & Reduce Cost In Bringing Anti-cancer Medicines to Patients

FCS physician abstract co-authors examine best practices to improve speed, efficiency & reduce cost in bringing anti-cancer medicines to patients.

FCS welcomes board-certified hematologist and medical oncologist Daniel Ezekwudo, MD, PhD to our North Port Cancer Center and Port Charlotte clinic.
FCS Welcomes Daniel Ezekwudo, MD, PhD

Florida Cancer Specialists & Research Institute Welcomes Board-certified Hematologist & Medical Oncologist Daniel Ezekwudo, MD, PhD To Charlotte County

Marcia Schmidt, MD, gynecologic oncologist joins Florida Cancer Specialists & Research Institute in Palm Beach County.
FCS Expands Specialized Gynecologic Oncology Services

Marcia Schmidt, MD, gynecologic oncologist joins Florida Cancer Specialists & Research Institute in Palm Beach County.

Dr. Judy Wang of Florida Cancer Specialists & Research Institute leads study on cancer immunotherapy.
Judy Wang, MD is Lead Author of Manuscript Detailing Investigational Treatment to Improve Immunotherapy Outcomes for Patients with Advanced Cancers

Florida Cancer Specialists & Research Institute associate director Judy Wang, MD, is lead author of a manuscript on oral bacterial therapy to improve immunotherapy outcomes.

Dr. Hussein met with His Majesty King Abdullah II of Jordan to strengthen ties with Jordanian medical professionals working in the U.S.
Maen Hussein, MD Meets With King Abdullah II Ahead of UN General Assembly to Strengthen U.S.–Jordan Medical Ties

Dr. Hussein met with His Majesty King Abdullah II of Jordan to strengthen ties with Jordanian medical professionals working in the U.S.

FCS real-world evidence published in Journal of Modern Economics.
FCS Utilizes Proprietary Real-World Data in First Study of Treatment Response in Lower-Risk Myelodysplastic Syndrome Patients Treated with Erythropoiesis-Stimulating Agents

Florida Cancer Specialists & Research Institute data leads to study on blood cancer being published in the Journal of Modern Economics.

FCS appoints new physician leadership.
Physician-Owned Practice Reinforces Commitment to Physician Leadership

Florida Cancer Specialists & Research Institute, a physician-owned practice, reinforces its commitment to physician leadership.

Jacqueline Ambrose appointed to the position of FCS General Counsel.
FCS Announces Addition to Executive Management Team

Jacqueline Ambrose appointed to FCS executive management team as general counsel.

FCS physicians and leaders present at SOHO 2025.
FCS Clinical Expertise And Real-World Evidence Capabilities Advancing Treatment of Blood Cancers

Florida Cancer Specialists & Research Institute physicians and leaders present advances in hematologic care at the 2025 SOHO annual meeting.

Troy Fishman, MD and Yeshanew Teklie, MD join Florida Cancer Specialists & Research Institute in Pinellas County and The Villages.
FCS Welcomes New Physicians to Statewide Practice

Troy Fishman, MD and Yeshanew Teklie, MD join Florida Cancer Specialists & Research Institute in Pinellas County and The Villages.

Strategic Alliance Partnerships

Through our strategic alliance partnership with MJH Life Sciences®, FCS is part of a national network of leading oncology experts sharing the latest news in cancer research and best treatment practices to continuously improve the quality of life for our patients.

OncLive logo
Targeted Oncology SAP
Pharmacy Times SAP logo
AJMC Partnership Seal
Cure Partnership seal
Oncology Nursing News seal